Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
3.000
-0.130 (-4.15%)
At close: Nov 16, 2026, 4:00 PM EST
2.960
-0.040 (-1.33%)
After-hours: Nov 16, 2026, 7:30 PM EST

Coya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-30.17-21.23-14.88-7.99-12.24-4.89
Depreciation & Amortization
0.020.030.030.030.030.02
Other Amortization
----1-
Asset Writedown & Restructuring Costs
1.812.290.030.540.53-
Stock-Based Compensation
5.154.292.660.870.210.23
Other Operating Activities
----2.5-
Change in Accounts Payable
1.34-0.530.480.30.850.67
Change in Unearned Revenue
-0.490.450.31.5--
Change in Other Net Operating Assets
0.523.951.1-6.44-0.090.07
Operating Cash Flow
-21.83-10.74-10.29-11.19-7.24-3.9
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.39-----0.14
Sale (Purchase) of Intangibles
-1.16-1.16-0.03-0.54-0.53-
Investing Cash Flow
-1.56-1.16-0.03-0.54-0.53-0.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----10.47-
Total Debt Issued
----10.47-
Net Debt Issued (Repaid)
----10.47-
Issuance of Common Stock
31.320.3916.1638.4300
Other Financing Activities
-0.24--0.13--1.11-0.34
Financing Cash Flow
31.0620.3916.0338.439.36-0.34

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
7.678.485.7126.691.59-4.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-22.22-10.74-10.29-11.19-7.24-4.04
Free Cash Flow Growth
------
Free Cash Flow Margin
-473.89%-135.16%-289.50%-186.41%--
Free Cash Flow Per Share
-1.03-0.64-0.68-1.10-2.79-1.56
Levered Free Cash Flow
-13.56-4.61-6.73-10.33-3.43-2.45
Unlevered Free Cash Flow
-13.56-4.61-6.73-10.33-4.43-2.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.373.881.88-4.640.750.74
SEC Filings: 10-K · 10-Q